Skip to main content
🎂 — | ♂/♀ M/F | ⚖️ — kg | 📏 — cm | BMI — | 👟 —
⚡ 88%
🩺 Chronic Disease Meds

ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖꯒꯤꯗꯃꯛꯇꯥ ꯁꯦꯛꯁꯒ꯭ꯂꯤꯞꯇꯤꯟ ꯑꯃꯁꯨꯡ ꯃꯦꯇꯐꯣꯔꯃꯤꯟ ꯇꯦꯕꯜ (Kombiglyze XR)ꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯅꯥ ꯈꯪꯖꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

MBBS
Medically Reviewed by MBBS ✓ Medically Reviewed
📅 Updated: Jul 15, 2026 • ⏱ 6 min read • ꯑꯦꯗꯤꯇꯣꯔꯤꯌꯜ ꯄꯣꯂꯤꯁꯤ꯫
ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖꯒꯤꯗꯃꯛꯇꯥ ꯁꯦꯛꯁꯒ꯭ꯂꯤꯞꯇꯤꯟ ꯑꯃꯁꯨꯡ ꯃꯦꯇꯐꯣꯔꯃꯤꯟ ꯇꯦꯕꯜ (Kombiglyze XR)ꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯅꯥ ꯈꯪꯖꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫
Table of Contents ▾

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ ꯂꯩꯔꯕꯗꯤ, ꯍꯥꯌꯕꯗꯤ ꯇꯥꯏꯞ 2 ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ ꯂꯩꯔꯕꯗꯤ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯀꯄꯨ ꯁꯥꯛꯁꯥꯒ꯭ꯂꯤꯞꯇꯤꯟ ꯑꯃꯁꯨꯡ ꯃꯦꯇꯐꯣꯔꯃꯤꯟ ꯗ꯭ꯔꯒꯁꯤꯡ ꯌꯥꯎꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯥ ꯄꯤꯔꯀꯄꯥ ꯌꯥꯏ꯫ ꯑꯩꯈꯣꯌꯒꯤ ꯂꯩꯕꯥꯛ ꯑꯁꯤꯗꯥ ꯃꯁꯤ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯌꯥꯝꯅꯥ ꯎꯕꯥ ꯐꯪꯏ ꯃꯗꯨꯗꯤ ꯀꯣꯝꯕꯤꯒ꯭ꯂꯥꯏꯖ ꯑꯦꯛꯁ.ꯑꯥꯔ. ꯃꯁꯤ ꯃꯤꯑꯣꯏ ꯀꯌꯥꯗꯥ ꯄꯤꯕꯥ ꯑꯐꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯅꯤ ꯑꯃꯁꯨꯡ ꯃꯁꯤꯅꯥ ꯆꯤꯅꯤ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯏ꯫ ꯑꯗꯨꯅꯥ ꯉꯁꯤ ꯑꯩꯈꯣꯌꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯤ ꯃꯔꯃꯗꯥ ꯅꯤꯡꯊꯤꯖꯅꯥ ꯈꯉꯂꯁꯤ ꯑꯃꯁꯨꯡ ꯃꯁꯤ ꯁꯤꯖꯤꯟꯅꯔꯀꯄꯥ ꯃꯇꯃꯗꯥ ꯆꯦꯀꯁꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ ꯈꯉꯂꯁꯤ꯫

⚡ Interactive Clinical Tool
⚖️

BMI Calculator

Know your body mass index (BMI) and weight classification

Open Interactive Calculator →

ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯇꯁꯦꯡꯅꯥ ꯀꯔꯤ ꯊꯣꯛꯂꯤꯕꯅꯣ?

ꯌꯥꯝꯅꯥ ꯂꯥꯏꯅꯥ ꯍꯥꯌꯔꯕꯗꯥ, ꯃꯁꯤ ꯇꯥꯏꯞ 2 ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯅꯕꯥ ꯄꯤꯕꯅꯤ꯫ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯄꯦꯅꯛꯔꯤꯑꯦꯖꯅꯥ ꯏꯅꯁꯨꯂꯤꯟ ꯄꯨꯊꯣꯀꯄꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯏ, ꯅꯍꯥꯛꯀꯤ ꯂꯤꯚꯔꯅꯥ ꯆꯤꯅꯤ ꯄꯨꯊꯣꯀꯄꯥ ꯍꯟꯊꯍꯜꯂꯤ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯀꯤ ꯍꯀꯆꯥꯡꯒꯤ ꯁꯦꯂꯁꯤꯡꯅꯥ ꯆꯤꯅꯤ ꯁꯣꯀꯍꯅꯕꯗꯥ ꯍꯦꯟꯅꯥ ꯂꯥꯌꯍꯜꯂꯤ꯫ ꯃꯁꯤ ꯄꯨꯝꯅꯃꯛ ꯑꯁꯤꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔꯒꯤ ꯆꯥꯡ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯏ꯫

ꯑꯗꯨꯕꯨ ꯃꯁꯤ ꯐꯖꯅꯥ ꯅꯤꯡꯁꯤꯡꯕꯤꯌꯨ꯫ ꯃꯁꯤ ꯈꯛꯇꯅꯥ ꯅꯍꯥꯛꯅꯥ ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯕꯥ ꯉꯃꯗꯦ꯫ ꯑꯐꯕꯥ ꯗꯥꯏꯠ ꯑꯃꯁꯨꯡ ꯅꯨꯃꯤꯠ ꯈꯨꯗꯤꯡꯒꯤ ꯑꯦꯛꯁꯔꯁꯥꯏꯖ ꯇꯧꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯅꯍꯥꯛꯅꯥ ꯁꯣꯌꯗꯅꯥ ꯇꯧꯒꯗꯕꯥ ꯊꯕꯛ ꯑꯅꯤꯅꯤ꯫

ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯂꯧꯗ꯭ꯔꯤꯉꯩ ꯃꯃꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

ꯑꯣꯀꯦ, ꯍꯧꯖꯤꯛꯇꯤ ꯃꯁꯤ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯁꯔꯨꯛ ꯑꯣꯏꯔꯦ꯫ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯍꯧꯗ꯭ꯔꯤꯉꯩꯗꯥ, ꯅꯍꯥꯛꯀꯤ ꯍꯀꯆꯥꯡꯗꯥ ꯂꯩꯔꯤꯕꯥ ꯑꯇꯩ ꯂꯥꯌꯅꯥ ꯑꯃꯍꯦꯛꯇꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯕꯥ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯀꯤ ꯂꯃꯆꯠ-ꯁꯥꯖꯠꯁꯤꯡ ꯑꯗꯨ ꯈꯪꯍꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯃꯔꯃꯗꯤ, ꯀꯟꯗꯤꯁꯟ ꯈꯔꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯁꯤꯖꯤꯟꯅꯕꯅꯥ ꯔꯤꯁ꯭ꯛ ꯂꯩꯕꯥ ꯌꯥꯏ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯈꯥꯗꯥ ꯄꯤꯔꯤꯕꯥ ꯑꯁꯤꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯑꯃꯍꯦꯛꯇꯕꯨ ꯂꯩꯔꯕꯗꯤ, ꯃꯗꯨꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯁꯣꯌꯗꯅꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯀꯟꯗꯤꯁꯅꯁꯤꯡ ꯑꯁꯤ ꯂꯩꯔꯕꯗꯤ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯜꯂꯨ꯫
ꯀꯤꯗꯅꯤꯒꯤ ꯂꯥꯌꯅꯥ ꯅꯠꯠꯔꯒꯥ ꯂꯤꯚꯔꯒꯤ ꯂꯥꯌꯅꯥ꯫
ꯍꯥꯔꯇꯀꯤ ꯂꯥꯌꯅꯥ, ꯃꯔꯨꯑꯣꯏꯅꯥ ꯍꯥꯔꯠ ꯐꯦꯜ ꯑꯣꯏꯕꯥ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯃꯥꯡꯗꯥ ꯄꯦꯅꯛꯔꯤꯑꯦꯇꯤꯁ ꯂꯩꯔꯕꯗꯤ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯌꯨ ꯊꯀꯄꯥ ꯇꯥꯔꯕꯗꯤ꯫
ꯑꯦꯅꯤꯃꯤꯌꯥ ꯅꯠꯠꯔꯒꯥ ꯚꯤꯇꯥꯃꯤꯟ B12 ꯋꯥꯠꯄꯥ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯇꯥꯏꯞ 1 ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ ꯂꯩꯔꯕꯗꯤ (ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯅꯍꯥꯛꯀꯤꯗꯃꯛꯇꯥ ꯅꯠꯇꯦ)
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯒꯥꯂꯕ꯭ꯂꯦꯗꯔ ꯗꯤꯖꯤꯖ ꯅꯠꯠꯔꯒꯥ ꯕ꯭ꯂꯗ ꯇ꯭ꯔꯥꯏꯒ꯭ꯂꯤꯁꯔꯥꯏꯗꯀꯤ ꯆꯥꯡ ꯋꯥꯡꯈꯠꯂꯕꯗꯤ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯏꯅꯐꯦꯛꯁꯟ ꯑꯃꯥ ꯂꯩꯔꯕꯗꯤ ꯅꯠꯠꯔꯒꯥ ꯁꯔꯖꯔꯤ ꯇꯧꯈ꯭ꯔꯕꯗꯤ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯤꯔꯣꯜꯂꯤꯕꯥ ꯑꯣꯏꯔꯕꯗꯤ, ꯃꯤꯔꯣꯅꯕꯥ ꯍꯣꯠꯅꯔꯕꯗꯤ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯛꯂꯤꯕꯥ ꯑꯣꯏꯔꯕꯗꯤ꯫
ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯃꯥꯡꯗꯥ ꯑꯇꯣꯞꯄꯥ ꯍꯤꯗꯥꯛ ꯅꯠꯠꯔꯒꯥ ꯆꯤꯟꯖꯥꯛ ꯑꯃꯗꯥ ꯑꯦꯂꯥꯔꯖꯤ ꯂꯩꯔꯕꯗꯤ꯫

ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯑꯁꯤ ꯀꯔꯝꯅꯥ ꯂꯧꯒꯅꯤ? ꯑꯆꯨꯝꯕꯥ ꯃꯑꯣꯡꯗꯥ꯫

ꯃꯁꯤꯗꯁꯨ ꯑꯗꯣꯝꯅꯥ ꯌꯥꯝꯅꯥ ꯅꯤꯡꯊꯤꯖꯅꯥ ꯊꯕꯛ ꯇꯧꯕꯥ ꯃꯊꯧ ꯇꯥꯏ꯫

  • ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯍꯥꯌꯔꯀꯄꯒꯨꯝꯅꯥ, ꯑꯆꯨꯝꯕꯥ ꯃꯇꯃꯗꯥ ꯆꯥꯒꯗꯕꯅꯤ꯫
  • ꯃꯍꯧꯁꯥꯅꯥ ꯃꯁꯤ ꯅꯨꯃꯤꯗꯥꯡꯒꯤ ꯆꯥꯛꯂꯦꯅꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯂꯧꯏ ꯍꯥꯌꯅꯥ ꯍꯥꯌꯅꯩ .
  • ꯇꯦꯕ꯭ꯂꯦꯠ ꯑꯗꯨ ꯏꯁꯤꯡꯒꯤ ꯒ꯭ꯂꯥꯁ ꯑꯃꯅꯥ ꯃꯄꯨꯡꯐꯥꯅꯥ ꯊꯀꯎ꯫
  • ꯃꯔꯨꯑꯣꯏꯕꯥ: ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯊꯨꯒꯥꯏꯕꯥ, ꯀꯨꯄꯁꯤꯅꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯆꯦꯅꯕꯥ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯈꯨꯗꯣꯡꯊꯤꯅꯤꯉꯥꯏ ꯑꯣꯏ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯃꯗꯨ ꯇꯧꯔꯣꯏꯗꯕꯅꯤ . ꯃꯁꯤ ꯅꯨꯃꯤꯠ ꯈꯨꯗꯤꯡꯒꯤ ꯍꯤꯗꯥꯛ ꯑꯗꯨ ꯇꯞꯅꯥ ꯇꯞꯅꯥ ꯔꯤꯂꯤꯖ ꯇꯧꯅꯕꯥ ꯁꯦꯃꯈꯤꯕꯅꯤ (Extended-Release)꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯗꯨ ꯊꯨꯒꯥꯏꯔꯕꯗꯤ, ꯍꯤꯗꯥꯛ ꯑꯗꯨꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯍꯀꯆꯥꯡꯗꯥ ꯑꯃꯨꯛ ꯍꯟꯅꯥ ꯆꯪꯂꯀꯄꯥ ꯌꯥꯏ ꯑꯃꯁꯨꯡ ꯁꯥꯊꯤꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫
  • ꯗꯣꯛꯇꯔꯒꯤ ꯄꯥꯎꯇꯥꯛ ꯌꯥꯎꯗꯅꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯑꯗꯨ ꯈꯪꯍꯧꯗꯅꯥ ꯊꯀꯄꯥ ꯂꯦꯄꯀꯅꯨ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯗꯣꯖ ꯑꯃꯥ ꯁꯣꯟꯊꯔꯕꯗꯤ: ꯅꯍꯥꯛꯅꯥ ꯅꯤꯡꯁꯤꯡꯂꯀꯄꯥ ꯃꯇꯃꯗꯥ ꯌꯥꯝꯅꯥ ꯊꯨꯅꯥ ꯂꯧ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯀꯤ ꯃꯊꯪꯒꯤ ꯗꯣꯖꯒꯤ ꯃꯇꯝ ꯌꯧꯔꯛꯂꯕꯗꯤ, ꯃꯥꯡꯈꯤꯕꯥ ꯗꯣꯖ ꯑꯗꯨ ꯊꯥꯗꯣꯀꯎ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯀꯤ ꯃꯊꯪꯒꯤ ꯗꯣꯖ ꯑꯗꯨ ꯁꯦꯗ꯭ꯌꯨꯜ ꯇꯧꯔꯕꯥ ꯃꯇꯝ ꯑꯗꯨꯗꯥ ꯂꯧ꯫ ꯀꯩꯗꯧꯉꯩꯗꯥ ꯃꯇꯝ ꯑꯃꯗꯥ ꯗꯣꯖ ꯑꯅꯤ ꯂꯧꯔꯣꯏꯗꯕꯅꯤ꯫

ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯂꯧꯕꯥ ꯃꯇꯃꯗꯥ ꯆꯦꯀꯁꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯂꯧꯕꯥ ꯃꯇꯃꯗꯥ ꯈꯔꯥ ꯆꯦꯀꯁꯤꯅꯕꯁꯨ ꯃꯊꯧ ꯇꯥꯏ꯫

ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯃꯦꯗꯤꯀꯦꯜ ꯆꯦꯀꯑꯞ ꯇꯧꯕꯥ꯫

ꯅꯍꯥꯛꯀꯤ ꯀꯟꯗꯤꯁꯟ ꯑꯗꯨ ꯌꯦꯡꯁꯤꯟꯅꯕꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯧ꯫ ꯃꯗꯨꯒꯤ ꯃꯇꯨꯡꯗꯥ ꯃꯍꯥꯛꯅꯥ ꯅꯍꯥꯛꯀꯤ HbA1C (A1C) ꯀꯧꯕꯥ ꯇꯦꯁ꯭ꯠ ꯑꯃꯥ ꯄꯥꯡꯊꯣꯛꯀꯅꯤ꯫ ꯃꯁꯤꯅꯥ ꯍꯧꯈꯤꯕꯥ ꯊꯥ 2-3ꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ ꯑꯗꯨ ꯀꯌꯥꯝ ꯐꯖꯅꯥ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯈꯤꯕꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯂꯦꯄꯊꯣꯀꯏ꯫ ꯃꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯇꯦꯁ꯭ꯠ ꯑꯃꯅꯤ꯫

ꯅꯍꯥꯛꯀꯤ ꯆꯤꯅꯤꯒꯤ ꯆꯥꯡ ꯑꯗꯨ ꯌꯦꯡꯁꯤꯜꯂꯨ꯫

ꯌꯨꯃꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔꯒꯤ ꯆꯥꯡ ꯑꯗꯨ ꯀꯔꯝꯅꯥ ꯇꯦꯁ꯭ꯠ ꯇꯧꯒꯗꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯈꯪꯖꯤꯅꯕꯤꯌꯨ꯫ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ ꯅꯦꯝꯕꯥ (Hypoglycemia) ꯑꯃꯁꯨꯡ ꯍꯥꯏ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ (Hyperglycemia)ꯒꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯈꯪꯖꯤꯅꯒꯗꯕꯅꯤ꯫

ꯆꯤꯅꯤ ꯅꯦꯝꯕꯥ ꯃꯇꯃꯗꯥ, ꯑꯦꯃꯔꯖꯦꯟꯁꯤ ꯑꯃꯗꯥ꯫ꯃꯇꯝ ꯄꯨꯝꯅꯃꯛꯇꯥ ꯆꯤꯅꯤ ꯈꯔꯥ, ꯇꯣꯐꯤ ꯑꯃꯥ ꯅꯠꯠꯔꯒꯥ ꯒ꯭ꯂꯨꯀꯣꯖ ꯇꯦꯕ꯭ꯂꯦꯠ ꯑꯃꯥ ꯃꯅꯥꯛ ꯅꯀꯄꯗꯥ ꯊꯝꯃꯨ꯫ ꯑꯗꯨꯕꯨ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯀꯤ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ ꯑꯗꯨ ꯅꯍꯥꯛꯅꯥ ꯋꯥꯈꯜ ꯇꯥꯗꯕꯥ ꯃꯑꯣꯡꯗꯥ ꯍꯟꯊꯔꯛꯂꯕꯗꯤ, ꯅꯍꯥꯛꯀꯤ ꯃꯤꯠꯇꯥ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯃꯠꯇꯥ ꯊꯃꯒꯅꯨ꯫ ꯅꯍꯥꯛꯅꯥ ꯁꯣꯀꯄꯥ ꯌꯥꯏ꯫ ꯑꯁꯤꯒꯨꯝꯕꯥ ꯀꯦꯁ ꯑꯃꯗꯥ , ꯅꯍꯥꯛꯅꯥ ꯃꯁꯥꯃꯀꯄꯨ ꯈꯨꯗꯛꯇꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯜ ꯑꯃꯒꯤ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯇ꯭ꯔꯤꯇꯃꯦꯟꯇ ꯌꯨꯅꯤꯠ (ETU)ꯗꯥ ꯄꯨꯈꯠꯀꯗꯕꯅꯤ꯫

ꯑꯇꯣꯞꯄꯥ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

  • ꯆꯥꯅꯕꯥ ꯄꯣꯠꯂꯃꯁꯤꯡ ꯊꯥꯗꯣꯛꯂꯣꯏꯗꯕꯅꯤ꯫
  • ꯌꯨ ꯊꯀꯄꯥ: ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯁꯤꯖꯤꯟꯅꯔꯤꯉꯩꯗꯥ ꯌꯨ ꯊꯀꯄꯥ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯈꯨꯗꯣꯡꯊꯤꯅꯤꯉꯥꯏ ꯑꯣꯏ꯫ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯕꯤꯌꯨ꯫
  • ꯃꯤꯔꯣꯅꯕꯥ: ꯍꯤꯗꯥꯛ ꯑꯁꯤꯅꯥ ꯅꯨꯄꯤ ꯈꯔꯗꯗꯤ ꯑꯃꯨꯛ ꯍꯟꯅꯥ ꯃꯤꯔꯣꯅꯕꯥ ꯌꯥꯕꯒꯤ ꯆꯥꯡ ꯍꯦꯅꯒꯠꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯆꯥꯔꯤꯉꯩꯗꯥ ꯃꯇꯤꯛ ꯆꯥꯕꯥ ꯕꯔꯊ ꯀꯟꯠꯔꯣꯂꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯧ꯫
  • ꯁꯔꯖꯔꯤ ꯑꯃꯁꯨꯡ ꯁ꯭ꯀꯦꯟ ꯇꯧꯕꯥ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯁꯔꯖꯔꯤ, ꯑꯦꯝ.ꯑꯥꯔ.ꯑꯥꯏ., ꯅꯠꯠꯔꯒꯥ ꯁꯤ.ꯇꯤ. ꯅꯨꯃꯤꯠꯁꯤꯡ ꯑꯗꯨꯒꯤꯗꯃꯛ ꯅꯍꯥꯛꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯗꯨ ꯊꯀꯄꯥ ꯂꯦꯄꯍꯅꯕꯥ ꯃꯊꯧ ꯇꯥꯕꯥ ꯌꯥꯏ꯫
  • ꯇꯦꯕ꯭ꯂꯦꯠ ꯑꯗꯨ ꯁ꯭ꯇꯣꯂꯗꯥ ꯄꯥꯁ ꯇꯧꯔꯀꯏ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯇꯃꯗꯥ ꯅꯍꯥꯛꯅꯥ ꯁ꯭ꯇꯣꯂꯗꯥ ꯑꯁꯪꯕꯥ ꯇꯦꯕ꯭ꯂꯦꯠ ꯁꯦꯜ ꯑꯗꯨ ꯊꯣꯀꯄꯥ ꯎꯕꯥ ꯐꯪꯒꯅꯤ꯫ ꯃꯁꯤ ꯅꯣꯔꯃꯦꯂꯅꯤ, ꯑꯗꯨꯕꯨ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯁꯤ ꯌꯥꯝꯅꯥ ꯇꯣꯏꯅꯥ ꯊꯣꯛꯂꯕꯗꯤ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯍꯥꯌꯌꯨ .

ꯑꯣꯏꯊꯣꯀꯄꯥ ꯌꯥꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ꯫

ꯍꯤꯗꯥꯛ ꯑꯃꯍꯦꯛꯇꯒꯨꯝꯅꯥ, ꯃꯁꯤꯅꯥ ꯃꯤꯑꯣꯏ ꯈꯔꯗꯗꯤ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯃꯤꯄꯨꯝ ꯈꯨꯗꯤꯡꯃꯛꯅꯥ ꯇꯧꯔꯣꯏ꯫ ꯑꯗꯨꯕꯨ ꯍꯥꯌꯔꯤꯕꯁꯤꯡ ꯑꯁꯤ ꯈꯉꯕꯥ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫

ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ꯫ ꯋꯥꯔꯣꯜ
ꯈꯨꯗꯛꯇꯥ ꯗꯣꯛꯇꯔꯗꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯒꯗꯕꯥ ꯁꯥꯊꯤꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ꯫
ꯑꯦꯂꯥꯔꯖꯤꯒꯤ ꯔꯤꯑꯦꯛꯁꯅꯁꯤꯡ꯫ ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯃꯥꯌ, ꯃꯤꯠ, ꯖꯤꯕ ꯅꯠꯠꯔꯒꯥ ꯀꯣꯛ ꯆꯤꯀꯄꯥ, ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ꯫
ꯂꯦꯛꯇꯤꯛ ꯑꯦꯁꯤꯗꯣꯁꯤꯁ꯫ ꯃꯁꯤ ꯌꯥꯝꯅꯥ ꯇꯣꯏꯅꯥ ꯊꯣꯀꯄꯥ ꯑꯗꯨꯕꯨ ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯀꯟꯗꯤꯁꯟ ꯑꯃꯅꯤ꯫ ꯃꯁꯜ ꯁꯣꯟꯊꯕꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ, ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ, ꯌꯥꯝꯅꯥ ꯋꯥꯅꯥ ꯋꯥꯈꯜ ꯇꯥꯕꯥ꯫
ꯄꯦꯅꯛꯔꯤꯑꯦꯇꯥꯏꯇꯤꯁ ꯂꯩꯕꯥ꯫ꯃꯊꯛꯀꯤ ꯈꯣꯡꯗꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯅꯥꯕꯥ (radiating to the back ), ꯆꯥꯕꯥ ꯊꯀꯄꯥ ꯂꯣꯏꯔꯕꯥ ꯃꯇꯨꯡꯗꯥ ꯍꯦꯟꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯅꯥꯕꯥ, ꯂꯥꯏꯍꯧ, ꯋꯥꯈꯜ ꯆꯔꯥꯡꯅꯕꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ꯫
ꯍꯥꯔꯠ ꯐꯦꯜ ꯑꯣꯏꯕꯥ꯫ ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ, ꯈꯣꯡ ꯑꯃꯁꯨꯡ ꯈꯣꯡꯗꯥ ꯁꯣꯀꯄꯥ, ꯈꯪꯍꯧꯗꯅꯥ ꯑꯔꯨꯝꯕꯥ ꯍꯦꯅꯒꯠꯂꯀꯄꯥ, ꯌꯥꯝꯅꯥ ꯋꯥꯅꯥ ꯋꯥꯈꯜ ꯋꯥꯕꯥ꯫
ꯁꯔꯨ ꯇꯥꯡꯁꯤꯡꯗꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯅꯥꯕꯥ꯫ ꯁꯔꯨ ꯇꯥꯡꯁꯤꯡꯗꯥ ꯁꯥꯊꯤꯅꯥ ꯁꯣꯀꯄꯥ꯫
ꯃꯍꯧꯁꯥꯅꯥ ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯣꯏꯗꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ, ꯑꯗꯨꯕꯨ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯈꯣꯌ ꯑꯁꯤ ꯂꯦꯡꯗꯅꯥ ꯂꯩꯔꯕꯗꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯒꯗꯕꯅꯤ꯫
ꯈꯣꯡ ꯍꯥꯝꯗꯕ ꯃꯁꯤ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯍꯧꯕꯒꯤ ꯑꯍꯥꯅꯕꯥ ꯇꯥꯉ꯭ꯀꯀꯁꯤꯡꯗꯥ ꯍꯦꯟꯅꯥ ꯀꯃꯟ ꯑꯣꯏ꯫
ꯍꯦꯗ-ꯑꯦꯛ, ꯅꯣꯡꯃꯩ ꯀꯥꯞꯄꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ꯫ ꯍꯥꯌꯔꯤꯕꯁꯤꯡ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯇꯣꯏꯅꯥ ꯊꯣꯀꯄꯥ ꯌꯥꯏ꯫
ꯀꯣꯜꯗ-ꯂꯥꯏꯛ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ꯫ ꯀꯣꯛ ꯁꯣꯀꯄꯥ, ꯅꯥꯀꯣꯡ ꯁꯣꯀꯄꯥ꯫

ꯑꯣꯚꯔꯗꯣꯖ ꯇꯧꯕꯥ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯈꯜꯂꯤꯕꯗꯒꯤ ꯍꯦꯟꯅꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯆꯥꯔꯦ ꯍꯥꯌꯅꯥ ꯈꯜꯂꯕꯗꯤ, ꯊꯦꯡꯊꯕꯥ ꯇꯧꯔꯣꯏꯗꯕꯅꯤ ꯑꯃꯁꯨꯡ ꯈꯨꯗꯛꯇꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯅꯀꯄꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯜ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯌꯨꯅꯤꯠ (ETU)ꯗꯥ ꯆꯠꯂꯨ ꯅꯠꯠꯔꯒꯥ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯅꯕꯒꯤꯗꯃꯛ ꯀꯣꯂꯝꯕꯣ ꯅꯦꯁꯅꯦꯜ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯂꯩꯕꯥ ꯅꯦꯁꯅꯦꯜ ꯄꯣꯏꯖꯅꯁ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯁꯦꯟꯇꯔꯗꯥ ꯐꯣꯟ ꯇꯧ꯫

ꯇꯦꯛ-ꯍꯣꯝ ꯃꯦꯁꯦꯖ ꯇꯧꯕꯥ꯫

  • ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯇꯥꯏꯞ 2 ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯅꯕꯥ ꯄꯤꯕꯅꯤ꯫ ꯑꯐꯕꯥ ꯗꯥꯏꯠ ꯑꯃꯁꯨꯡ ꯑꯦꯛꯁꯔꯁꯥꯏꯖꯁꯨ ꯇꯉꯥꯏꯐꯗꯕꯥ ꯑꯃꯅꯤ꯫
  • ꯇꯦꯕ꯭ꯂꯦꯠ ꯑꯗꯨ ꯊꯨꯒꯥꯌꯒꯅꯨ, ꯀꯨꯄꯁꯤꯜꯂꯨ ꯅꯠꯠꯔꯒꯥ ꯆꯥꯀꯎ꯫ ꯃꯄꯨꯡ ꯐꯥꯅꯥ ꯂꯧꯊꯣꯀꯎ꯫ ꯃꯍꯧꯁꯥꯅꯥ ꯃꯁꯤ ꯅꯨꯃꯤꯗꯥꯡꯋꯥꯏꯔꯃꯗꯥ ꯆꯥꯛ ꯊꯣꯡꯕꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯂꯧꯏ꯫
  • ꯅꯍꯥꯛꯅꯥ ꯂꯧꯔꯤꯕꯥ ꯑꯇꯩ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯅꯥ ꯂꯩꯔꯤꯕꯥ ꯑꯇꯩ ꯃꯦꯗꯤꯀꯦꯜ ꯀꯟꯗꯤꯁꯅꯁꯤꯡꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯁꯣꯌꯗꯅꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ꯫
  • ꯍꯥꯏꯄꯣꯒ꯭ꯂꯥꯏꯁꯦꯃꯤꯌꯥ ꯑꯃꯁꯨꯡ ꯍꯥꯏꯄꯔꯒ꯭ꯂꯥꯏꯁꯦꯃꯤꯌꯥꯒꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ ꯈꯪꯖꯤꯅꯒꯗꯕꯅꯤ꯫ ꯑꯦꯃꯔꯖꯦꯟꯁꯤꯁꯤꯡꯒꯤꯗꯃꯛꯇꯥ ꯆꯤꯅꯤ ꯈꯔꯗꯤ ꯈꯨꯠꯇꯥ ꯊꯝꯃꯨ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯈꯣꯝꯂꯥꯡ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯁ꯭ꯕꯔ ꯍꯣꯅꯕꯥ ꯋꯥꯕꯥ, ꯅꯠꯠꯔꯒꯥ ꯃꯥꯌ/ ꯈꯣꯟꯖꯦꯜ ꯁꯣꯀꯄꯥ ꯑꯁꯤꯅꯆꯤꯡꯕꯥ ꯁꯥꯊꯤꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯑꯃꯠꯇꯥ ꯂꯩꯔꯕꯗꯤ ꯈꯨꯗꯛꯇꯥ ꯃꯦꯗꯤꯀꯦꯂꯒꯤ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯕꯤꯌꯨ꯫
ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ, ꯁꯦꯛꯁꯒ꯭ꯂꯤꯞꯇꯤꯟ, ꯃꯦꯇꯐꯣꯔꯃꯤꯟ, ꯀꯣꯝꯕꯤꯒ꯭ꯂꯥꯏꯖ ꯑꯦꯛꯁꯑꯥꯔ, ꯆꯤꯅꯤ ꯀꯟꯠꯔꯣꯜ, ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ ꯍꯤꯗꯥꯛ, ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ꯫

👩🏽 ⚕️ ꯑꯍꯦꯅꯕꯥ ꯋꯥꯍꯪꯁꯤꯡ (FAQs)

❓ FAQ

FAQ

Evidence-based clinical answers to common patient questions

💬 ꯁꯦꯛꯁꯒ꯭ꯂꯤꯞꯇꯤꯟ ꯑꯃꯁꯨꯡ ꯃꯦꯇꯐꯣꯔꯃꯤꯟ (Saxagliptin; Metformin / Kombiglyze XR) ꯑꯁꯤ ꯀꯔꯤꯒꯤꯗꯃꯛꯇꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯥ ꯑꯣꯏꯕꯒꯦ?

ꯃꯁꯤ ꯌꯥꯝꯅꯥ ꯏꯐꯦꯛꯇꯤꯕ (XR / ꯀꯟꯇꯤꯟꯌꯨꯑꯣꯁ) ꯄꯤꯜ ꯑꯃꯅꯤ ꯃꯁꯤꯅꯥ ‘ꯇꯥꯏꯞ ꯲ ꯗꯥꯏꯕꯦꯇꯤꯁ’ ꯂꯩꯕꯥ ꯑꯅꯥꯕꯁꯤꯡꯗꯥ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔꯒꯤ ꯆꯥꯡ ꯋꯥꯡꯅꯥ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯅꯕꯥ ꯇꯣꯉꯥꯟ ꯇꯣꯉꯥꯅꯕꯥ ꯃꯑꯣꯡ ꯑꯅꯤꯗꯥ ꯊꯕꯛ ꯇꯧꯕꯥ ꯗ꯭ꯔꯒ ꯑꯅꯤ ꯄꯨꯅꯁꯤꯜꯂꯤ! ꯃꯦꯇꯐꯣꯔꯃꯤꯟ ꯈꯛꯇꯅꯥ ꯆꯤꯅꯤꯒꯤ ꯆꯥꯡ ꯍꯟꯊꯔꯀꯄꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯒꯤꯗꯃꯛ ꯗꯣꯛꯇꯔꯁꯤꯡꯅꯥ ‘ꯁꯛꯁꯥꯒ꯭ꯂꯤꯞꯇꯤꯟ (ꯗꯤ.ꯄꯤ.ꯄꯤ.-꯴ ꯏꯅꯍꯤꯕꯤꯇꯔ)’ ꯀꯧꯕꯥ ꯑꯅꯧꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯃꯤꯛꯁ ꯇꯧꯔꯕꯥ ꯑꯈꯟꯅꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯔꯤꯀꯃꯦꯟꯗ ꯇꯧꯔꯤ꯫

💬 ꯗ꯭ꯔꯒ ꯑꯅꯤ ꯑꯁꯤꯅꯥ (ꯃꯦꯇꯐꯣꯔꯃꯤꯟ + ꯁꯦꯛꯁꯥꯒ꯭ꯂꯤꯞꯇꯤꯟ) ꯄꯨꯟꯅꯥ ꯑꯩꯈꯣꯌꯒꯤ ꯆꯤꯅꯤ ꯑꯁꯤ ꯀꯔꯝꯅꯥ ꯍꯟꯊꯍꯜꯂꯤ/ꯀꯟꯠꯔꯣꯜ ꯇꯧꯔꯤꯕꯒꯦ?

ꯃꯁꯤꯅꯥ ꯃꯥꯌꯀꯩ ꯑꯅꯤꯃꯛꯇꯒꯤ ꯑꯦꯇꯦꯛ ꯇꯧꯏ! 1. ꯃꯦꯇꯐꯣꯔꯃꯤꯅꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯂꯤꯚꯔꯅꯥ ꯑꯅꯧꯕꯥ ꯆꯤꯅꯤ (ꯒ꯭ꯂꯨꯀꯣꯖ) ꯄꯨꯊꯣꯀꯄꯥ ꯍꯟꯊꯍꯜꯂꯤ ꯑꯃꯁꯨꯡ ꯍꯧꯖꯤꯛ ꯂꯩꯔꯤꯕꯥ ꯆꯤꯅꯤ ꯑꯗꯨ ꯃꯁꯂꯁꯤꯡꯅꯥ ꯁꯣꯀꯍꯟꯅꯕꯥ ꯐꯣꯔꯁ ꯇꯧꯏ꯫ 2. ꯑꯇꯣꯞꯄꯥ ꯃꯦꯖꯤꯛ ꯑꯗꯨꯗꯤ ꯁꯦꯛꯁꯒ꯭ꯂꯤꯞꯇꯤꯅꯅꯤ! ꯑꯩꯈꯣꯌꯅꯥ ꯆꯥꯛ ꯆꯥꯕꯥ ꯃꯇꯃꯗꯥ, ꯏꯟꯇꯦꯁ꯭ꯇꯥꯏꯅꯁꯤꯡꯅꯥ ꯍꯣꯔꯃꯣꯟ (Incretin) ꯑꯃꯥ ꯄꯨꯊꯣꯀꯏ, ꯃꯗꯨꯅꯥ ꯄꯦꯅꯛꯔꯤꯑꯦꯖꯗꯥ ꯏꯅꯁꯨꯂꯤꯟ ꯍꯦꯅꯒꯠꯍꯟꯅꯕꯥ ꯍꯥꯌꯔꯤ꯫ ꯁꯦꯛꯁꯒ꯭ꯂꯤꯞꯇꯤꯅꯅꯥ ꯃꯁꯤ ‘ꯏꯅꯛꯔꯦꯇꯤꯟ (ꯗꯤ.ꯄꯤ.ꯄꯤ.-꯴ ꯑꯦꯅꯖꯥꯏꯝ) ꯃꯥꯡꯍꯅꯕꯥ ꯊꯤꯡꯗꯨꯅꯥ’, ꯏꯅꯁꯨꯂꯤꯟ ꯄꯨꯊꯣꯀꯄꯥ ꯍꯦꯅꯒꯠꯍꯟꯗꯨꯅꯥ ꯑꯃꯁꯨꯡ ꯆꯥꯕꯥ ꯂꯣꯏꯔꯕꯥ ꯃꯇꯨꯡꯗꯥ ꯂꯥꯀꯄꯥ ꯆꯤꯅꯤ ꯍꯟꯊꯍꯟꯗꯨꯅꯥ ꯇꯧꯏ꯫

💬 ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ ꯍꯟꯊꯔꯕꯁꯨ, ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ ꯑꯁꯤ ꯂꯧꯔꯤꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯅꯥ ꯈꯪꯖꯤꯅꯒꯗꯕꯥ ꯈꯨꯗꯣꯡꯊꯤꯅꯤꯉꯥꯏ ꯑꯣꯏꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ ꯑꯗꯨ ꯀꯔꯤꯅꯣ?

ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯆꯥꯎꯕꯥ ꯁꯃꯁ꯭ꯌꯥ ꯑꯁꯤ ꯁꯦꯛꯁꯒ꯭ꯂꯤꯞꯇꯤꯅꯅꯥ ꯊꯣꯀꯍꯅꯕꯥ ꯁꯃꯁ꯭ꯌꯥꯁꯤꯡꯅꯤ! ꯃꯁꯤꯅꯥ ꯂꯪꯁꯇꯥ ꯏꯁꯤꯡ ꯊꯨꯃꯖꯤꯅꯕꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ, ꯑꯃꯁꯨꯡ ꯍꯥꯔꯠ ꯐꯦꯜ ꯑꯣꯏꯕꯒꯤ ꯔꯤꯁ꯭ꯛ ꯋꯥꯡꯕꯥ (ꯃꯔꯨꯑꯣꯏꯅꯥ ꯍꯥꯔꯇꯀꯤ ꯄ꯭ꯔꯣꯕ꯭ꯂꯦꯝ ꯂꯩꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯗꯥ) ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ ꯍꯥꯌꯅꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯔꯀꯈꯤ꯫ ꯑꯇꯣꯞꯄꯥ ꯁꯤꯍꯅꯕꯥ ꯌꯥꯕꯥ ꯈꯨꯗꯣꯡꯊꯤꯕꯥ ꯑꯃꯗꯤ ꯃꯁꯤꯅꯥ ꯃꯤꯑꯣꯏ ꯈꯔꯗꯗꯤ ‘ꯑꯦꯛꯌꯨꯠ ꯄꯦꯅꯛꯔꯤꯑꯦꯇꯤꯁ’ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ (ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯀꯤ ꯈꯣꯡꯗꯥ/ ꯈꯣꯡꯗꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯅꯥꯕꯥ ꯂꯩꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯧ!)꯫

🔍 Search Keywords: saxagliptin metformin extended release tablets • saxagliptin metformin extended release tablets symptoms • saxagliptin metformin extended release tablets causes and treatment • saxagliptin metformin extended release tablets sri lanka • ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖꯒꯤꯗꯃꯛꯇꯥ ꯁꯦꯛꯁꯒ꯭ꯂꯤꯞꯇꯤꯟ ꯑꯃꯁꯨꯡ ꯃꯦꯇꯐꯣꯔꯃꯤꯟ ꯇꯦꯕꯜ (Kombiglyze XR)ꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯅꯥ ꯈꯪꯖꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

🩺 Articles For You

ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖꯒꯤ ꯑꯦ.꯱.ꯁꯤ.ꯒꯤ ꯇꯦꯁ꯭ꯠ ꯑꯁꯤ ꯑꯩꯈꯣꯌꯅꯥ ꯇꯁꯦꯡꯅꯥ ꯈꯉꯂꯕꯔꯥ? (HbA1c) ꯑꯃꯁꯨꯡ ꯑꯦꯟ.

ꯕ꯭ꯂꯗ ꯒ꯭ꯂꯨꯀꯣꯖ ꯇꯦꯁ꯭ꯇꯀꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯅꯥ ꯈꯪꯖꯤꯅꯒꯗꯕꯥ ꯄꯨꯝꯅꯃꯛ꯫

ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ (Dieting with Diabetes)ꯅꯥ ꯑꯔꯨꯝꯕꯥ ꯍꯟꯊꯍꯟꯅꯕꯥ ꯍꯣꯠꯅꯔꯤꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯒꯤꯗꯃꯛ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯇꯤꯄꯁ 9

ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖꯒꯥ ꯃꯔꯤ ꯂꯩꯅꯕꯥ ꯈꯣꯡꯒꯤ ꯀꯟꯗꯤꯁꯅꯁꯤꯡꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯈꯣꯡꯗꯥ ꯀꯔꯤ ꯇꯧꯕꯥ ꯌꯥꯕꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯇꯁꯦꯡꯅꯥ ꯈꯪꯖꯤꯅꯁꯤ!

ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖꯗꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯈꯨꯗꯣꯡꯊꯤꯅꯤꯉꯥꯏ ꯑꯣꯏꯕꯥ ꯑꯦꯃꯔꯖꯦꯟꯁꯤ! ꯗꯤ.ꯀꯦ.ꯑꯦ.(ꯗꯥꯏꯕꯦꯇꯤꯛ ꯀꯦꯇꯣꯑꯦꯁꯤꯗꯣꯁꯤꯁ)ꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯈꯉꯖꯤꯅꯁꯤ

ꯅꯍꯥꯛꯅꯥ ꯈꯪꯍꯧꯗꯅꯥ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ ꯍꯟꯊꯔꯀꯄꯁꯨ ꯊꯦꯡꯅꯕ꯭ꯔꯥ? ꯍꯥꯏꯄꯣꯒ꯭ꯂꯥꯏꯁꯦꯃꯤꯌꯥꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯋꯥꯔꯤ ꯁꯥꯁꯤ!

💬 Patient Questions & Comments (0)

Have a question or experience to share? Post a comment or reply to other readers below.

🛡️ Plain Text Only • No Links
👤

No comments yet. Be the first to share your question or experience below.

⚠️ Important: Medical articles and information on Nirogi Lanka are strictly for educational and awareness purposes and do not substitute professional medical advice, diagnosis, or treatment. Always consult a qualified physician for any medical concerns.